94 related articles for article (PubMed ID: 10469315)
1. Identification of epitopes on tyrosinase which are recognized by autoantibodies from patients with vitiligo.
Kemp EH; Waterman EA; Gawkrodger DJ; Watson PF; Weetman AP
J Invest Dermatol; 1999 Aug; 113(2):267-71. PubMed ID: 10469315
[TBL] [Abstract][Full Text] [Related]
2. Molecular mapping of epitopes on melanocyte-specific protein Pmel17 which are recognized by autoantibodies in patients with vitiligo.
Kemp EH; Waterman EA; Gawkrodger DJ; Watson PF; Weetman AP
Clin Exp Immunol; 2001 Jun; 124(3):509-15. PubMed ID: 11472416
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies in vitiligo patients recognize multiple domains of the melanin-concentrating hormone receptor.
Gottumukkala RV; Waterman EA; Herd LM; Gawkrodger DJ; Watson PF; Weetman AP; Kemp EH
J Invest Dermatol; 2003 Oct; 121(4):765-70. PubMed ID: 14632194
[TBL] [Abstract][Full Text] [Related]
4. Detection of tyrosinase autoantibodies in patients with vitiligo using 35S-labeled recombinant human tyrosinase in a radioimmunoassay.
Kemp EH; Gawkrodger DJ; MacNeil S; Watson PF; Weetman AP
J Invest Dermatol; 1997 Jul; 109(1):69-73. PubMed ID: 9204957
[TBL] [Abstract][Full Text] [Related]
5. Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2).
Kemp EH; Gawkrodger DJ; Watson PF; Weetman AP
Clin Exp Immunol; 1997 Sep; 109(3):495-500. PubMed ID: 9328128
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to human melanocyte-specific protein pmel17 in the sera of vitiligo patients: a sensitive and quantitative radioimmunoassay (RIA).
Kemp EH; Gawkrodger DJ; Watson PF; Weetman AP
Clin Exp Immunol; 1998 Dec; 114(3):333-8. PubMed ID: 9844040
[TBL] [Abstract][Full Text] [Related]
7. Epitopes, avidity and IgG subclasses of tyrosine hydroxylase autoantibodies in vitiligo and alopecia areata patients.
Rahoma SF; Sandhu HK; McDonagh AJ; Gawkrodger DJ; Weetman AP; Kemp EH
Br J Dermatol; 2012 Jul; 167(1):17-28. PubMed ID: 22329856
[TBL] [Abstract][Full Text] [Related]
8. Proteomic scan for tyrosinase peptide antigenic pattern in vitiligo and melanoma: role of sequence similarity and HLA-DR1 affinity.
Lucchese A; Willers J; Mittelman A; Kanduc D; Dummer R
J Immunol; 2005 Nov; 175(10):7009-20. PubMed ID: 16272362
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay.
Kemp EH; Waterman EA; Gawkrodger DJ; Watson PF; Weetman AP
Br J Dermatol; 1998 Nov; 139(5):798-805. PubMed ID: 9892944
[TBL] [Abstract][Full Text] [Related]
10. Tyrosinase as an autoantigen in patients with vitiligo.
Baharav E; Merimski O; Shoenfeld Y; Zigelman R; Gilbrud B; Yecheskel G; Youinou P; Fishman P
Clin Exp Immunol; 1996 Jul; 105(1):84-8. PubMed ID: 8697641
[TBL] [Abstract][Full Text] [Related]
11. Oxidized tyrosinase: A possible antigenic stimulus for non-segmental vitiligo autoantibodies.
Al-Shobaili HA; Rasheed Z
J Dermatol Sci; 2015 Sep; 79(3):203-13. PubMed ID: 26137927
[TBL] [Abstract][Full Text] [Related]
12. Definition of anti-tyrosinase MAb T311 linear determinant by proteome-based similarity analysis.
Willers J; Lucchese A; Mittelman A; Dummer R; Kanduc D
Exp Dermatol; 2005 Jul; 14(7):543-50. PubMed ID: 15946243
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic T lymphocyte reactivity to gp100, MelanA/MART-1, and tyrosinase, in HLA-A2-positive vitiligo patients.
Mandelcorn-Monson RL; Shear NH; Yau E; Sambhara S; Barber BH; Spaner D; DeBenedette MA
J Invest Dermatol; 2003 Sep; 121(3):550-6. PubMed ID: 12925214
[TBL] [Abstract][Full Text] [Related]
14. Reactivity to tyrosinase: expression in cancer (melanoma) and autoimmunity (vitiligo).
Merimsky O; Shoenfeld Y; Baharav E; Zigelman R; Fishman P
Hum Antibodies Hybridomas; 1996; 7(4):151-6. PubMed ID: 9140726
[TBL] [Abstract][Full Text] [Related]
15. Vitiligo antibodies are not directed to tyrosinase.
Xie Z; Chen D; Jiao D; Bystryn JC
Arch Dermatol; 1999 Apr; 135(4):417-22. PubMed ID: 10206048
[TBL] [Abstract][Full Text] [Related]
16. Immunity to melanin and to tyrosinase in melanoma patients, and in people with vitiligo.
Dorđić M; Matić IZ; Filipović-Lješković I; Džodić R; Sašić M; Erić-Nikolić A; Vuletić A; Kolundžija B; Damjanović A; Grozdanić N; Nikolić S; Pralica J; Dobrosavljević D; Rašković S; Andrejević S; Juranić Z
BMC Complement Altern Med; 2012 Jul; 12():109. PubMed ID: 22834951
[TBL] [Abstract][Full Text] [Related]
17. Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles.
Kawakami Y; Robbins PF; Wang X; Tupesis JP; Parkhurst MR; Kang X; Sakaguchi K; Appella E; Rosenberg SA
J Immunol; 1998 Dec; 161(12):6985-92. PubMed ID: 9862734
[TBL] [Abstract][Full Text] [Related]
18. The role of tyrosinase in autoimmune vitiligo.
Song YH; Connor E; Li Y; Zorovich B; Balducci P; Maclaren N
Lancet; 1994 Oct; 344(8929):1049-52. PubMed ID: 7934446
[TBL] [Abstract][Full Text] [Related]
19. [Expression and purification of epitope peptide of human tyrosinase and its antigenicity in vitiligo patients].
Guan CP; Zhou MN; Li YW; Wei XD; Xu AE
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2408-11. PubMed ID: 18036319
[TBL] [Abstract][Full Text] [Related]
20. Mammalian tyrosinase-related protein-1 is recognized by autoantibodies from vitiliginous Smyth chickens. An avian model for human vitiligo.
Austin LM; Boissy RE
Am J Pathol; 1995 Jun; 146(6):1529-41. PubMed ID: 7778691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
